Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

Vaccines against the novel coronavirus SARS-CoV-2 have now been available for several months (Zaqout et al., 2021). Determination of spike-protein specific antibodies after SARS-CoV-2 vaccination, although not unrestrictedly recommended (Centers for Disease Control and Prevention, 2021), is commonly performed. The post-vaccination antibody levels, even when measured with standardized commercially available CE-certified quantitative test systems, differ significantly (Kristiansen et al., 2021, Perkmann et al., 2021a).

Source: International Journal of Infectious Diseases - July 28, 2021 Category: Infectious Diseases Authors: Thomas Perkmann, Nicole Perkmann-Nagele, Patrick Mucher, Astrid Radakovics, Manuela Repl, Thomas Koller, Galateja Jordakieva, Oswald F Wagner, Christoph J Binder, Helmuth Haslacher Source Type: research